Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of verteporfin therapy on central visual field function.

Ursula M Schmidt-Erfurth1, Hanno Elsner, Naim Terai

  • 1Department of Ophthalmology, University of Schleswig-Holstein, Luebeck, Germany.

Ophthalmology
|May 4, 2004
PubMed
Summary

Photodynamic therapy with verteporfin significantly preserved central visual field function in patients with age-related macular degeneration. This treatment reduced scotoma size, potentially improving reading ability and visual rehabilitation outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual Acuity and Quality of Life Outcomes With Pegcetacoplan Treatment: A Post Hoc Analysis From the OAKS and DERBY Trials.

American journal of ophthalmology·2025
Same author

A Novel Effect of Microaneurysms and Retinal Cysts on Capillary Perfusion in Diabetic Macular Edema: A Multimodal Imaging Study.

Journal of clinical medicine·2025
Same author

Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration.

Scientific reports·2025
Same author

Association Between Corneal Changes and Retinal Oximetry in Diabetes Mellitus.

Clinical ophthalmology (Auckland, N.Z.)·2024
Same author

Multiple instance learning based classification of diabetic retinopathy in weakly-labeled widefield OCTA en face images.

Scientific reports·2023
Same author

Comparison of Stimulus Types for Retinotopic Cortical Mapping of Macular Disease.

Translational vision science & technology·2023

Area of Science:

  • Ophthalmology
  • Medical Research

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Subfoveal choroidal neovascularization (CNV) significantly impairs central vision.
  • Maintaining central visual field function is crucial for daily activities.

Purpose of the Study:

  • To evaluate the efficacy of photodynamic therapy (PDT) using verteporfin.
  • To assess the impact of verteporfin PDT on central visual field maintenance.
  • To compare visual field outcomes between verteporfin treatment and placebo with laser therapy.

Main Methods:

  • Randomized controlled clinical trial involving 46 patients with subfoveal CNV.
  • Patients were assigned to either standard verteporfin therapy (33 patients) or placebo with laser treatment (13 patients).

Related Experiment Videos

  • Macular microperimetry using a scanning laser ophthalmoscope (SLO) was conducted over 2 years to measure absolute and relative scotoma sizes.

    • Main Results:

    • Verteporfin therapy resulted in significantly smaller absolute and relative scotoma sizes compared to placebo at all intervals from 6 to 24 months (P<0.001).
    • In the verteporfin group, absolute scotoma size increased from 2.5 mm² to 7.3 mm², while in the placebo group it increased from 2.7 mm² to 31.5 mm².
    • Relative scotoma size increased from 7.9 mm² to 20.8 mm² in the verteporfin group, versus 8.5 mm² to 48.3 mm² in the placebo group.

    Conclusions:

    • Photodynamic therapy with verteporfin demonstrated a significant benefit in preserving central visual field function.
    • The reduction in scotoma size suggests improved visual function and potential benefits for reading ability.
    • Verteporfin therapy offers a promising approach for visual rehabilitation in AMD patients with CNV.